These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11305813)
1. Membranous glomerulonephritis in a patient with inherited activated protein C resistance. Regéczy N; Lakos G; Balogh I; Kappelmayer J; Kiss E Clin Nephrol; 2000 May; 53(5):390-3. PubMed ID: 11305813 [TBL] [Abstract][Full Text] [Related]
2. [Activated protein C resistance--a recently discovered hereditary thrombophilia]. Moland L; Sandset PM Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3590-5. PubMed ID: 9820002 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837 [TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion. España F; Villa P; Mira Y; Grancha S; Royo M; Estellés A; Vayá A; Aznar J Haematologica; 1999 Jan; 84(1):80-4. PubMed ID: 10091395 [TBL] [Abstract][Full Text] [Related]
5. Association of primary antiphospholipid syndrome with inherited activated protein C resistance. Picillo U; De Lucia D; Palatiello E; Scuotto A; Marcialis MR; Pezzella S; Tirri G J Rheumatol; 1998 Jun; 25(6):1232-4. PubMed ID: 9632093 [TBL] [Abstract][Full Text] [Related]
7. Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Hendler MF; Meschengieser SS; Blanco AN; Alberto MF; Salviú MJ; Gennari L; Lazzari MA Am J Hematol; 2004 Aug; 76(4):330-7. PubMed ID: 15282664 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of thrombotic children with malignancy. Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962 [TBL] [Abstract][Full Text] [Related]
9. Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndrome. Alarcón-Segovia D; Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A J Rheumatol; 1996 Dec; 23(12):2162-5. PubMed ID: 8970058 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis associated with coagulation disorders and immunethyreopathy. Benten D; Widjaja A; von Depka M; Flemming P; Trautwein C; Böker K; Vogel A; Rosenau J; Manns MP Z Gastroenterol; 2001 Oct; 39(10):837-40. PubMed ID: 11605152 [TBL] [Abstract][Full Text] [Related]
11. [National evaluation of the diagnosis of activated protein C resistance]. Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684 [TBL] [Abstract][Full Text] [Related]
12. Activated protein C resistance in anterior ischaemic optic neuropathy. Nagy V; Facsko A; Takacs L; Balazs E; Berta A; Balogh I; Edes I; Czuriga I; Pfliegler G Acta Ophthalmol Scand; 2004 Apr; 82(2):140-3. PubMed ID: 15043529 [TBL] [Abstract][Full Text] [Related]
13. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041 [TBL] [Abstract][Full Text] [Related]
14. Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice. Levy Y; Ziporen L; Gilburd B; George J; Polak-Charcon S; Amital H; Cledes J; Youinou P; Shoenfeld Y Hum Antibodies Hybridomas; 1996; 7(3):91-6. PubMed ID: 9057056 [TBL] [Abstract][Full Text] [Related]
15. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. Bladt V; Steengaard-Pedersen K; Poulsen LH; Petersen OB; Laursen B; d'Amore F Eur J Haematol; 2004 Dec; 73(6):437-40. PubMed ID: 15522067 [TBL] [Abstract][Full Text] [Related]
16. Thrombophilia and cancer. Horowitz N; Brenner B Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986 [TBL] [Abstract][Full Text] [Related]
17. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778 [TBL] [Abstract][Full Text] [Related]
18. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
19. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance. Staropoli JF; Van Cott EM; Makar RS Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of thrombophilia based on coagulation and genetic studies]. Bałszan-Kowalska I Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]